We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023.
- Authors
Kelly, Karen; Chansky, Kari; Gaspar, Laurie E; Albain, Kathy S; Jett, James; Ung, Yee C; Lau, Derick H M; Crowley, John J; Gandara, David R
- Abstract
Early clinical studies with gefitinib showed promising efficacy and mild toxicity in patients with advanced non-small-cell lung cancer (NSCLC). Thus, gefitinib was an ideal agent to evaluate in a maintenance setting in stage III disease.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Vol 26, Issue 15, p2450
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2007.14.4824